TP53 and neoplasm: Loss or mutation of the genome-guarding TP53 and impaired p53 function account for the majority of tumor cells [151], reviewed by [152] and without functional p53, downregulation of PLK1 is impaired leading to elevated PLK1 levels [102,111,149].